[Form 4] Rhinebeck Bancorp, Inc. Insider Trading Activity
Michael J. Quinn, President & CEO and Director of Rhinebeck Bancorp (RBKB), reported option exercise and share disposition on 09/09/2025. He exercised 95,100 stock options at an exercise price of $6.57 per share, and those options are fully vested. The same filing reports a disposition of 55,646 shares at a price of $13.00 per share. The Form 4 also lists indirect holdings including 7,401 shares in a 401(k), 3,357 shares in an ESOP, 10,100 shares in a spouse's IRA and 1,000 shares directly held by spouse. The filing is signed 09/11/2025.
- Exercise of 95,100 options at a relatively low $6.57 per share cost indicates utilization of existing compensation plan.
- Options are fully vested, as explicitly stated, supporting the legitimacy of the exercise.
- Complete disclosure of indirect holdings (401(k), ESOP, spouse accounts) improves transparency.
- Disposition of 55,646 shares at $13.00 reduces the reporting person\'s direct holdings.
- Form does not state the purpose of the sale or whether proceeds were used to satisfy tax withholding obligations.
Insights
TL;DR: Insider exercised a large block of fully vested options and sold a portion of resulting shares.
The reporting person exercised 95,100 options at $6.57, creating common stock ownership reflected in the filing. The report separately shows a disposition of 55,646 shares at $13.00. Both transactions are explicit in the Form 4 and indicate typical post-exercise selling activity rather than a silent transfer; the options are noted as fully vested which explains the exercise action. Impact to outstanding shares or company capital structure is not stated in the filing.
TL;DR: Transaction disclosure is complete on its face; options are vested and required Form 4 reporting was made.
The Form 4 discloses both acquisition via option exercise and a contemporaneous disposition of shares. The filer is identified as President & CEO and Director, and indirect holdings through employee plans and spouse accounts are itemized. The filing includes the exercise date, exercise price, sale price, and the exercisability and expiration dates for the options, meeting standard Section 16 transparency requirements. No regulatory issues or missing statement is identified within this document.